{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:01:22Z","timestamp":1790679682775,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s40122-026-00855-6","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T02:00:56Z","timestamp":1784340056000},"page":"1433-1445","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Outcomes after Onset of Mirogabalin-Related Adverse Drug Reactions in Patients with Lumbar Spinal Stenosis: Post Hoc Analysis of the MiroTAS Study"],"prefix":"10.1007","volume":"15","author":[{"given":"Takuya","family":"Nikaido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhito","family":"Shiosakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Sakoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"key":"855_CR1","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1093\/pm\/pnz161","volume":"20","author":"T Deer","year":"2019","unstructured":"Deer T, Sayed D, Michels J, Josephson Y, Li S, Calodney AK. A review of lumbar spinal stenosis with intermittent neurogenic claudication: disease and diagnosis. Pain Med. 2019;20:S32-44.","journal-title":"Pain Med"},{"key":"855_CR2","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3349\/ymj.2015.56.4.1044","volume":"56","author":"SY Park","year":"2015","unstructured":"Park SY, An HS, Moon SH, et\u00a0al. Neuropathic pain components in patients with lumbar spinal stenosis. Yonsei Med J. 2015;56:1044\u201350.","journal-title":"Yonsei Med J"},{"key":"855_CR3","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1097\/BRS.0000000000001553","volume":"41","author":"S Orita","year":"2016","unstructured":"Orita S, Yamashita T, Ohtori S, et\u00a0al. Prevalence and location of neuropathic pain in lumbar spinal disorders: analysis of 1804 consecutive patients with primary lower back pain. Spine (Phila Pa 1976). 2016;41:1224\u201331.","journal-title":"Spine (Phila Pa 1976)"},{"key":"855_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jos.2022.03.013","volume":"28","author":"M Kawakami","year":"2023","unstructured":"Kawakami M, Takeshita K, Inoue G, et\u00a0al. Japanese Orthopaedic Association (JOA) clinical practice guidelines on the management of lumbar spinal stenosis, 2021\u2014Secondary publication. J Orthop Sci. 2023;28:46\u201391.","journal-title":"J Orthop Sci"},{"key":"855_CR5","unstructured":"Mirogabalin besylate (Tarlige\u24c7) tablets [package insert, version 9]. Daiichi Sankyo Co., Ltd.; Tokyo, Japan: 2025. Available from: https:\/\/pins.japic.or.jp\/pdf\/newPINS\/00070625.pdf [In Japanese]. Cited 18 Feb 2026."},{"key":"855_CR6","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1097\/j.pain.0000000000001501","volume":"160","author":"J Kato","year":"2019","unstructured":"Kato J, Matsui N, Kakehi Y, Murayama E, Ohwada S, Sugihara M. Mirogabalin for the management of postherpetic neuralgia: a randomized, double-blind, placebo-controlled phase 3 study in Asian patients. Pain. 2019;160:1175\u201385.","journal-title":"Pain"},{"key":"855_CR7","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/jdi.13013","volume":"10","author":"M Baba","year":"2019","unstructured":"Baba M, Matsui N, Kuroha M, Wasaki Y, Ohwada S. Mirogabalin for the treatment of diabetic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase III study in Asian patients. J Diabetes Investig. 2019;10:1299\u2013306.","journal-title":"J Diabetes Investig"},{"key":"855_CR8","doi-asserted-by":"publisher","first-page":"e1193","DOI":"10.1212\/WNL.0000000000201709","volume":"100","author":"T Ushida","year":"2023","unstructured":"Ushida T, Katayama Y, Hiasa Y, et\u00a0al. Mirogabalin for central neuropathic pain after spinal cord injury: a randomized, double-blind, placebo-controlled, phase 3 study in Asia. Neurology. 2023;100:e1193\u2013206.","journal-title":"Neurology"},{"key":"855_CR9","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s40122-023-00513-1","volume":"12","author":"T Ushida","year":"2023","unstructured":"Ushida T, Katayama Y, Hiasa Y, et\u00a0al. Long-term safety and efficacy of mirogabalin for central neuropathic pain: a multinational, phase 3, 52-week, open-label study in Asia. Pain Ther. 2023;12:963\u201378.","journal-title":"Pain Ther"},{"key":"855_CR10","doi-asserted-by":"crossref","unstructured":"Nikaido T, Takatsuna H, Tabata S, Shiosakai K, Nakatani T, Konno SI. Efficacy and safety of add-on mirogabalin to NSAIDs in lumbar spinal stenosis with peripheral neuropathic pain: a randomized, open-label study. Pain Ther. 2022;11:1195\u2013214. [Erratum in: Pain Ther. 2022; 11:1215\u20137].","DOI":"10.1007\/s40122-022-00410-z"},{"key":"855_CR11","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s40122-025-00732-8","volume":"14","author":"T Nikaido","year":"2025","unstructured":"Nikaido T, Tabata S, Shiosakai K, Nakatani T, Sakoda H. Safety and efficacy of mirogabalin in lumbar spinal stenosis patients with peripheral neuropathic pain on NSAIDs: post hoc analysis of the MiroTAS study. Pain Ther. 2025;14:1293\u2013310.","journal-title":"Pain Ther"},{"key":"855_CR12","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2147\/JPR.S63028","volume":"7","author":"K Onouchi","year":"2014","unstructured":"Onouchi K, Koga H, Yokoyama K, Yoshiyama T. An open-label, long-term study examining the safety and tolerability of pregabalin in Japanese patients with central neuropathic pain. J Pain Res. 2014;7:439\u201347.","journal-title":"J Pain Res"},{"key":"855_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1080\/14656566.2022.2155048","volume":"24","author":"K Kato","year":"2023","unstructured":"Kato K, Kodama S, Shiosakai K, Kimura T. Relationship between the dose titration and adherence of mirogabalin in patients with peripheral neuropathic pain depending on renal function: a nationwide electronic medical record database study. Expert Opin Pharmacother. 2023;24:267\u201382.","journal-title":"Expert Opin Pharmacother"},{"key":"855_CR14","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s40122-025-00722-w","volume":"14","author":"T Hirai","year":"2025","unstructured":"Hirai T, Okawa A, Takahashi H, Shiosakai K, Yoshii T. Efficacy and safety of mirogabalin in patients with neuropathic pain due to cervical spondylotic radiculopathy: Miro-Cens, a randomized, controlled, interventional study. Pain Ther. 2025;14:1063\u201379.","journal-title":"Pain Ther"},{"key":"855_CR15","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s40122-025-00776-w","volume":"14","author":"H Suzuki","year":"2025","unstructured":"Suzuki H, Kaito T, Nakashima H, et\u00a0al. Efficacy and safety of mirogabalin as an add-on to nonsteroidal anti-inflammatory drugs for neuropathic pain caused by lumbar disc herniation: a randomized controlled study (Miro-Hers). Pain Ther. 2025;14:1879\u201398.","journal-title":"Pain Ther"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-026-00855-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-026-00855-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-026-00855-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:29:43Z","timestamp":1790677783000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-026-00855-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["855"],"URL":"https:\/\/doi.org\/10.1007\/s40122-026-00855-6","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]},"assertion":[{"value":"27 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Takuya Nikaido has received lecture fees from Daiichi Sankyo Co., Ltd. Kazuhito Shiosakai and Hiroshi Sakoda are employees of Daiichi Sankyo Co., Ltd.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The primary study was approved by the Clinical Research Review Committee, Fukushima Medical University Certified Review Board (CRB no. CRB2200002), which notified all participating centers of the approval. The primary study was conducted in accordance with the ethical principles, Clinical Trials Act, and relevant notifications stipulated in the Declaration of Helsinki (as revised in 2013). All patients provided written informed consent. The primary study was registered in the Japan Registry of Clinical Trials under identifier jRCTs021200007.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}